These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8739825)

  • 21. Effect of endotoxin on tirilazad mesylate (U74006F) pharmacokinetic parameters in neonatal calves.
    Rose ML; Semrad SD; Putnam ML; Brown SA
    J Vet Pharmacol Ther; 1993 Dec; 16(4):438-45. PubMed ID: 8126760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).
    STIPAS Investigators
    Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
    Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
    J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of tirilazad mesylate (U74006F) on cerebral oxygen consumption, and reactivity of cerebral blood flow to carbon dioxide in healthy volunteers.
    Olsen KS; Videbaek C; Agerlin N; Krøll M; Bøge-Rasmussen T; Paulson OB; Gjerris F
    Anesthesiology; 1993 Oct; 79(4):666-71. PubMed ID: 8214745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
    Fleishaker JC; Pearson LK; Pearson PG; Wienkers LC; Hopkins NK; Peters GR
    J Clin Pharmacol; 1999 Mar; 39(3):260-7. PubMed ID: 10073325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Gender and Menopausal Status on the Pharmacokinetics of Tirilazad Mesylate in Healthy Subjects.
    Fleishaker JC; Hulst-Pearson LK; Peters GR
    Am J Ther; 1995 Aug; 2(8):553-560. PubMed ID: 11854826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
    Kim H; Koehler RC; Hurn PD; Hall ED; Traystman RJ
    Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
    Lanzino G; Kassell NF
    J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.
    Laizure SC; Franklin LK; Kaiser DG; Williams CL; Stevens RC; Sanders PL; Miller M
    Drug Metab Dispos; 1993; 21(5):951-4. PubMed ID: 7902261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.
    Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
    Stroke; 1999 Feb; 30(2):450-5; discussion 455-6. PubMed ID: 9933286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate.
    Fleishaker JC; Hulst LK; Peters GR
    Pharm Res; 1994 Feb; 11(2):341-4. PubMed ID: 8165199
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
    Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
    Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous irritation, pharmacokinetics, and tissue distribution of tirilazad in rats following intravenous administration of a novel supersaturated submicron lipid emulsion.
    Wang Y; Mesfin GM; Rodríguez CA; Slatter JG; Schuette MR; Cory AL; Higgins MJ
    Pharm Res; 1999 Jun; 16(6):930-8. PubMed ID: 10397616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F).
    Feasby TE; Hahn AF; Lovgren D; Wilkie L
    Neuropathol Appl Neurobiol; 1994 Aug; 20(4):384-91. PubMed ID: 7808589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
    Matsui T; Asano T
    Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical efficacy of tirilazad mesylate for treatment of endotoxemia in neonatal calves.
    Rose ML; Semrad SD
    Am J Vet Res; 1992 Dec; 53(12):2305-10. PubMed ID: 1476313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat.
    Bågenholm R; Andiné P; Hagberg H
    Pediatr Res; 1996 Sep; 40(3):399-403. PubMed ID: 8865275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lazaroids. CNS pharmacology and current research.
    Clark WM; Hazel JS; Coull BM
    Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat.
    Hellström HO; Wanhainen A; Valtysson J; Persson L; Hillered L
    Acta Neurochir (Wien); 1994; 129(3-4):188-92. PubMed ID: 7847162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.